13
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Topical cyclosporin A fails to improve alopecia areata - a double blind study

, , , &
Pages 13-14 | Published online: 12 Jul 2009

References

  • Parodi A, Rebora A. Topical cyclosporine in alopecia areata. Arch Dermatol 1987; 123: 165
  • Thomson A W, Aldridge R D, Semel H F. Topical cyclosporine in alopecia areata and nickel contact dermatitis. Loncet 1986; ii: 971–2
  • De Prost Y, Teillac D, Paquez F, et al. Traitement de la pelade sevère par application topique de cyclosporine A. Étude comparative contre placébo chez 43 patients. Nouv Dermatol 1988; 7(suppl 1)46
  • Mauduit G, Lenvers H, Barthélemy H, Thivolet J. Traitement des pelades sevères par applications locales de cyclosporine A. Ann Dermatol Venereol 1987; 114: 507–10
  • Gilhar A, Pillar T, Etdoni A. Topical cyclosporine A in alopecia areata. Acta Derm Venereol 1989; 69: 252–3
  • Tosti A, Bardazzi F, Guerra L. Alopecia totalis: is treating nonresponder patients useful?. J Am Acad Dermatol 1991; 24: 455–6
  • Gupta A K, Ellis C N, Cooper K D, et al. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22: 242–50
  • Teshima H, Kihara H, Nakagawa T, Hori Y. Effective therapy with low dose of oral cyclosporine A and prednisolone for alopecia universalis. Jpn J Allergol 1990; 39: 714–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.